118 related articles for article (PubMed ID: 23267898)
21. [An assessment of therapeutic effects by transcatheter arterial embolization (TAE) with degradable starch microspheres (DSM) for hepatic malignant tumors].
Hirai K; Yamashita K; Aoki Y; Sakai T; Abe M; Tanikawa K; Noguchi H; Miyazono K; Kubo Y; Saitsu H
Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):772-80. PubMed ID: 2550567
[TBL] [Abstract][Full Text] [Related]
22. Successful laparoscopic radiofrequency ablation of hepatocellular carcinoma adhered to the mesentery after transcatheter arterial embolization.
Kurokohchi K; Masaki T; Himoto T; Deguchi A; Nakai S; Yoneyama H; Yoshida S; Kimura Y; Inoue H; Kinekawa F; Yoshitake A; Izuishi K; Watanabe S; Kuriyama S
Oncol Rep; 2005 Jan; 13(1):65-8. PubMed ID: 15583803
[TBL] [Abstract][Full Text] [Related]
23. [Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
Niinobu T; Shibata T; Fukushima Y; Kitada M; Tukahara Y; Hata S; Ikeda K; Hayashida H; Fuzita J; Takahashi Y; Nakamura T; Suzuki R; Shimano T; Takami M; Ishida T
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1931-5. PubMed ID: 11086448
[TBL] [Abstract][Full Text] [Related]
24. [Assessment of therapeutic effects by transcatheter arterial embolization (TAE) in hepatic malignant tumors with degradable starch microspheres (DSM)].
Hirai K; Yamashita K; Aoki Y; Fujimoto T; Tanaka M; Sakai T; Majima Y; Noguchi H; Miyazone K; Kubo Y
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2653-8. PubMed ID: 2843132
[TBL] [Abstract][Full Text] [Related]
25. Randomized controlled trial for the efficacy of hepatic arterial occlusion during radiofrequency ablation for small hepatocellular carcinoma--direct ablative effects and a long-term outcome.
Kobayashi M; Ikeda K; Kawamura Y; Hosaka T; Sezaki H; Yatsuji H; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
Liver Int; 2007 Apr; 27(3):353-9. PubMed ID: 17355457
[TBL] [Abstract][Full Text] [Related]
26. [A case report of unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus responding to DSM-TACE (degradable starch microspheres-transcatheter arterial chemoembolization)].
Kirihara M; Nagashima M; Higuchi K; Tahira H; Tajima M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2705-7. PubMed ID: 21224686
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
[TBL] [Abstract][Full Text] [Related]
28. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
Zhao M; Wu PH; Zeng YX; Xia JC; Zhang FJ; Xian LJ; Zhang YP; Zhou K; Fan WJ; Zhang L; Gao F; Zhou QM
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1823-8. PubMed ID: 17054858
[TBL] [Abstract][Full Text] [Related]
29. [Radiofrequency ablation for hepatocellular carcinoma].
Inagaki M; Yagi T; Sadamori H; Matsuda H; Matsukawa H; Ishikawa T; Tanaka N; Mimura H; Yasui K; Kanazawa S
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2242-5. PubMed ID: 12484046
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
[TBL] [Abstract][Full Text] [Related]
31. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
[TBL] [Abstract][Full Text] [Related]
32. Carbon dioxide-enhanced sonographically guided radiofrequency ablation combined with transcatheter arterial chemoembolization for sonographically undetectable hepatocellular carcinoma.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
Hepatogastroenterology; 2005; 52(65):1344-6. PubMed ID: 16201070
[TBL] [Abstract][Full Text] [Related]
33. Hepatic arteriography in patients with hepatocellular carcinoma: change in findings caused by balloon occlusion of tumor-draining hepatic veins.
Kanazawa S; Yasui K; Doke T; Mitogawa Y; Hiraki Y
AJR Am J Roentgenol; 1995 Dec; 165(6):1415-9. PubMed ID: 7484576
[TBL] [Abstract][Full Text] [Related]
34. Multimodality treatment with conventional transcatheter arterial chemoembolization and radiofrequency ablation for unresectable hepatocellular carcinoma.
Ashoori N; Paprottka P; Trumm C; Bamberg F; Kolligs FT; Rentsch M; Reiser MF; Jakobs TF
Digestion; 2012; 85(1):18-26. PubMed ID: 22156507
[TBL] [Abstract][Full Text] [Related]
35. In-vivo evaluation of a novel bipolar radiofrequency device for interstitial thermotherapy of liver tumors during normal and interrupted hepatic perfusion.
Ritz JP; Lehmann KS; Isbert C; Reissfelder C; Albrecht T; Stein T; Buhr HJ
J Surg Res; 2006 Jun; 133(2):176-84. PubMed ID: 16360176
[TBL] [Abstract][Full Text] [Related]
36. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
38. Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence.
Nishikawa H; Osaki Y; Kita R; Kimura T; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Saito S; Nasu A
Int J Oncol; 2012 Sep; 41(3):903-9. PubMed ID: 22692851
[TBL] [Abstract][Full Text] [Related]
39. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
[TBL] [Abstract][Full Text] [Related]
40. [Intermittent arterial chemoembolization in liver tumor using degradable starch microspheres].
Takayasu Y; Yokoyama H; Takehara M; Tabuchi Y; Kotake M
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1715-20. PubMed ID: 2167642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
